Latest Insider Transactions at Adverum Biotechnologies, Inc. (ADVM)
This section provides a real-time view of insider transactions for Adverum Biotechnologies, Inc. (ADVM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Adverum Biotechnologies, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Adverum Biotechnologies, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 09
2025
|
Laurent Fischer CEO, PRESIDENT AND DIRECTOR |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
522,666
-100.0%
|
-
|
|
Dec 09
2025
|
Laurent Fischer CEO, PRESIDENT AND DIRECTOR |
BUY
Grant, award, or other acquisition
|
Direct |
500,000
+48.89%
|
-
|
|
Dec 09
2025
|
Laurent Fischer CEO, PRESIDENT AND DIRECTOR |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
25,000
-100.0%
|
-
|
|
Dec 09
2025
|
Laurent Fischer CEO, PRESIDENT AND DIRECTOR |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
351,513
-100.0%
|
-
|
|
Dec 09
2025
|
Laurent Fischer CEO, PRESIDENT AND DIRECTOR |
BUY
Exercise of conversion of derivative security
|
Direct |
150,000
+29.91%
|
$600,000
$4.2 P/Share
|
|
Dec 09
2025
|
Rabia Gurses Ozden Chief Medical Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
85,000
-100.0%
|
-
|
|
Dec 09
2025
|
Rabia Gurses Ozden Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
85,000
+50.0%
|
-
|
|
Dec 09
2025
|
Rabia Gurses Ozden Chief Medical Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
8,125
-100.0%
|
-
|
|
Dec 09
2025
|
Peter Soparkar CHIEF OPERATING OFFICER |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
157,333
-100.0%
|
-
|
|
Dec 09
2025
|
Peter Soparkar CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+48.81%
|
-
|
|
Dec 09
2025
|
Peter Soparkar CHIEF OPERATING OFFICER |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
13,125
-100.0%
|
-
|
|
Dec 09
2025
|
Peter Soparkar CHIEF OPERATING OFFICER |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
80,189
-100.0%
|
-
|
|
Dec 09
2025
|
Linda M Rubinstein CHIEF FINANCIAL OFFICER |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
42,000
-100.0%
|
-
|
|
Dec 09
2025
|
Linda M Rubinstein CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
42,000
+50.0%
|
-
|
|
Dec 09
2025
|
Linda M Rubinstein CHIEF FINANCIAL OFFICER |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
8,125
-100.0%
|
-
|
|
Dec 09
2025
|
Linda M Rubinstein CHIEF FINANCIAL OFFICER |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
61,150
-100.0%
|
-
|
|
Dec 09
2025
|
Linda M Rubinstein CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
48,750
+44.36%
|
$195,000
$4.2 P/Share
|
|
Dec 09
2025
|
Setareh Seyedkazemi CHIEF DEVELOPMENT OFFICER |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
88,332
-100.0%
|
-
|
|
Dec 09
2025
|
Setareh Seyedkazemi CHIEF DEVELOPMENT OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
85,000
+49.04%
|
-
|
|
Dec 09
2025
|
Setareh Seyedkazemi CHIEF DEVELOPMENT OFFICER |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
8,125
-100.0%
|
-
|
|
Dec 09
2025
|
Setareh Seyedkazemi CHIEF DEVELOPMENT OFFICER |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
54,874
-100.0%
|
-
|
|
Dec 09
2025
|
Dawn Svoronos |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
5,000
-100.0%
|
-
|
|
Dec 09
2025
|
Lupher, Jr. Mark L. |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
13,000
-100.0%
|
-
|
|
Dec 09
2025
|
James Paul Scopa |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
10,333
-100.0%
|
-
|
|
Dec 09
2025
|
Patrick Machado |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
8,818
-100.0%
|
-
|
|
Dec 09
2025
|
Frazier Life Sciences Public Fund, L.P. |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
4,288,949
-100.0%
|
$12,866,847
$3.56 P/Share
|
|
Dec 08
2025
|
Laurent Fischer CEO, PRESIDENT AND DIRECTOR |
BUY
Open market or private purchase
|
Direct |
117,614
+36.85%
|
$470,456
$4.31 P/Share
|
|
Dec 05
2025
|
Peter Soparkar CHIEF OPERATING OFFICER |
BUY
Open market or private purchase
|
Direct |
50,000
+38.41%
|
$200,000
$4.22 P/Share
|
|
Dec 05
2025
|
Laurent Fischer CEO, PRESIDENT AND DIRECTOR |
BUY
Open market or private purchase
|
Direct |
11,085
+11.67%
|
$44,340
$4.24 P/Share
|
|
Dec 04
2025
|
Braden Michael Leonard |
SELL
Open market or private sale
|
Indirect |
524,560
-21.13%
|
$2,098,240
$4.19 P/Share
|
|
Dec 03
2025
|
Braden Michael Leonard |
SELL
Open market or private sale
|
Indirect |
222,925
-8.41%
|
$891,700
$4.17 P/Share
|
|
Dec 02
2025
|
Braden Michael Leonard |
SELL
Open market or private sale
|
Indirect |
51,961
-1.88%
|
$207,844
$4.2 P/Share
|
|
Dec 01
2025
|
Braden Michael Leonard |
SELL
Open market or private sale
|
Indirect |
300,000
-9.81%
|
$1,200,000
$4.2 P/Share
|
|
May 15
2025
|
Setareh Seyedkazemi CHIEF DEVELOPMENT OFFICER |
SELL
Open market or private sale
|
Direct |
924
-6.29%
|
$1,848
$2.0 P/Share
|
|
May 15
2025
|
Peter Soparkar CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
2,960
-7.03%
|
$5,920
$2.0 P/Share
|
|
May 15
2025
|
Laurent Fischer CEO, PRESIDENT AND DIRECTOR |
SELL
Open market or private sale
|
Direct |
9,126
-9.45%
|
$18,252
$2.0 P/Share
|
|
Apr 23
2025
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Direct |
50,000
+20.68%
|
$100,000
$2.98 P/Share
|
|
Apr 22
2025
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Indirect |
300,000
+8.94%
|
$900,000
$3.0 P/Share
|
|
Apr 02
2025
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Indirect |
15,209
+0.55%
|
$60,836
$4.04 P/Share
|
|
Mar 31
2025
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Indirect |
19,566
+0.71%
|
$78,264
$4.38 P/Share
|
|
Mar 27
2025
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Direct |
16,593
+10.48%
|
$82,965
$5.19 P/Share
|
|
Mar 27
2025
|
Braden Michael Leonard |
SELL
Open market or private purchase
|
Direct |
16,593
-10.48%
|
$82,965
$5.19 P/Share
|
|
Mar 26
2025
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Direct |
40,814
+14.01%
|
$204,070
$5.04 P/Share
|
|
Mar 20
2025
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Indirect |
30,600
+1.11%
|
$153,000
$5.61 P/Share
|
|
Mar 19
2025
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Indirect |
25,000
+0.92%
|
$100,000
$4.94 P/Share
|
|
Mar 18
2025
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Indirect |
62,341
+1.16%
|
$249,364
$4.67 P/Share
|
|
Feb 28
2025
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Indirect |
85,068
+3.16%
|
$340,272
$4.6 P/Share
|
|
Feb 27
2025
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Indirect |
86,802
+3.33%
|
$347,208
$4.46 P/Share
|
|
Feb 26
2025
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Indirect |
164,886
+6.35%
|
$659,544
$4.01 P/Share
|
|
Feb 25
2025
|
Linda M Rubinstein CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
8,125
+29.6%
|
-
|